Drug profile · INN
florbetaben (18f)
NEURACEQ
florbetaben (18f) (NEURACEQ) is a diagnostic agent.
EMA: approved Various (V09) V09AX06
Patents linked 4
Pipeline programs 18
News articles 0
Drug details — florbetaben (18f)
- Class
- Various (V09)
- Route
- —
- Patents
- 4
- Programs
- 18
- Data quality
- 0.83
Quick answer
florbetaben (18f) (NEURACEQ) is a diagnostic agent.
Key facts
INN florbetaben (18f)
Brand NEURACEQ
Mechanism Diagnostic agent
Therapeutic class Various (V09)
ATC code V09AX06
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 9320793
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
granted -
US 9006283
Methods of modifying amyloid β oligomers using non-peptidic compounds
granted -
US 8962677
Methods of restoring cognitive ability using non-peptidic compounds
granted -
US 7964359
Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance
granted
Frequently asked questions
What is florbetaben (18f)?
florbetaben (18f) (NEURACEQ) is a diagnostic agent.
What is the brand name for florbetaben (18f)?
NEURACEQ is a marketed brand name for florbetaben (18f). Check FDA Drugs@FDA for the current US label holder and prescribing information.